BRUEX
Price
$14.80
Change
+$0.15 (+1.02%)
Updated
Apr 23 closing price
Net Assets
275.93M
VIVAX
Price
$63.78
Change
+$0.44 (+0.69%)
Updated
Apr 23 closing price
Net Assets
190.51B
Ad is loading...

BRUEX vs VIVAX

Header iconBRUEX vs VIVAX Comparison
Open Charts BRUEX vs VIVAXBanner chart's image
MFS Blended Research Value Equity B
Price$14.80
Change+$0.15 (+1.02%)
VolumeN/A
Net Assets275.93M
Vanguard Value Index I
Price$63.78
Change+$0.44 (+0.69%)
VolumeN/A
Net Assets190.51B
BRUEX vs VIVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BRUEX vs. VIVAX commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRUEX is a Buy and VIVAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 191B vs. BRUEX (276M). VIVAX pays higher dividends than BRUEX: VIVAX (2.14) vs BRUEX (0.50). BRUEX was incepted earlier than VIVAX: BRUEX (10 years) vs VIVAX (32 years). BRUEX (1.60) is less costly to investors than VIVAX (0.17). BRUEX is a more actively managed with annual turnover of: 55.00 vs. VIVAX (10.00). BRUEX has a lower initial minimum investment than VIVAX: BRUEX (1000) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 2.68 vs. BRUEX (-8.05). VIVAX return over 5 years is better than : 68.72 vs. BRUEX (39.20).
BRUEXVIVAXBRUEX / VIVAX
Total Expense Ratio1.490.17876%
Annual Report Gross Expense Ratio1.600.17941%
Fund Existence10 years32 years-
Gain YTD-3.682-4.09290%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets276M191B0%
Annual Yield % from dividends0.502.1423%
Returns for 1 year-8.052.68-300%
Returns for 3 years-0.4611.96-4%
Returns for 5 years39.2068.7257%
Returns for 10 yearsN/A90.37-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GMOIX27.63N/A
N/A
GMO International Equity III
HFMRX25.38N/A
N/A
Hartford MidCap R3
EKJFX11.20N/A
N/A
Allspring Premier Large Co Gr R6
ABVAX15.88N/A
N/A
AB Large Cap Value A
MSEEX22.66N/A
N/A
Morgan Stanley Europe Opportunity C